Magnetic Resonance Imaging for Monitoring the Efficacy of Thrombolytic Therapy in Subacute Pulmonary Artery Embolism

Severe clinical symptoms and right ventricular impairment mandated thrombolytic therapy (intravenous urokinase), and the patient recovered rapidly within 72 h. One week later, repeat CMR imaging demonstrated improved right ventricular function; CMR pulmonary angiography could no longer detect the fo...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2009-09, Vol.54 (14), p.1335-1335
Main Authors: Jahnke, Cosima, MD, Kaufmann, Jan, MD, Stauber, Barbara, MD, Goetze, Stephan, MD, Fleck, Eckart, MD, Paetsch, Ingo, MD
Format: Article
Language:English
Subjects:
Aged
Biological and medical sciences
Blood and lymphatic vessels
Cardiology
Cardiology. Vascular system
Cardiovascular
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Female
Fibrinolytic Agents - therapeutic use
Heart attacks
Hospitals
Humans
Hypertrophy, Right Ventricular - drug therapy
Hypertrophy, Right Ventricular - pathology
Internal Medicine
Magnetic Resonance Angiography
Magnetic Resonance Imaging, Cine
Medical imaging
Medical sciences
Medical treatment
Pneumology
Pulmonary arteries
Pulmonary Artery - pathology
Pulmonary Embolism - drug therapy
Pulmonary Embolism - pathology
Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases
Urokinase-Type Plasminogen Activator - therapeutic use
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Severe clinical symptoms and right ventricular impairment mandated thrombolytic therapy (intravenous urokinase), and the patient recovered rapidly within 72 h. One week later, repeat CMR imaging demonstrated improved right ventricular function; CMR pulmonary angiography could no longer detect the formerly seen thrombi but confirmed increased visibility of peripheral pulmonary vessels (B and E).
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2009.03.087